Skip to main content

Andres Maldonado

Stock Analyst at H.C. Wainwright

Total Price Targets
4
Stocks Covered
4
Sectors
Healthcare
Most Recent
Jan 26, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • ENGN+218.1%
    enGene Holdings Inc.
    $25.00 targetDec 3, 2025
  • PVLA+63.3%
    Palvella Therapeutics, Inc.
    $75.00 targetAug 15, 2025
  • SRRK+31.0%
    Scholar Rock Holding Corporation
    $58.00 targetJan 26, 2026

Most Bearish

  • SRRK+31.0%
    Scholar Rock Holding Corporation
    $58.00 targetJan 26, 2026
  • PVLA+63.3%
    Palvella Therapeutics, Inc.
    $75.00 targetAug 15, 2025
  • ENGN+218.1%
    enGene Holdings Inc.
    $25.00 targetDec 3, 2025

Stocks Covered by Andres Maldonado

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
SRRKScholar Rock Holding Corporation$58.00$46.75+24.1%1Jan 26, 2026
ENGNenGene Holdings Inc.$25.00$7.24+245.3%1Dec 3, 2025
PVLAPalvella Therapeutics, Inc.$75.00$125.87-40.4%1Aug 15, 2025
CGONCG Oncology, Inc. Common stock$75.00$66.29+13.1%1Sep 17, 2024

Recent Activity

  • Jan 26, 2026— Set$58.00price target onSRRK(Scholar Rock Holding Corporation)
  • Dec 3, 2025— Set$25.00price target onENGN(enGene Holdings Inc.)
  • Aug 15, 2025— Set$75.00price target onPVLA(Palvella Therapeutics, Inc.)
  • Sep 17, 2024— Set$75.00price target onCGON(CG Oncology, Inc. Common stock)

Frequently Asked Questions

Who is Andres Maldonado?

Andres Maldonado is a stock analyst at H.C. Wainwright covering 4 stocks primarily in Healthcare. They have issued 4 price targets since Sep 17, 2024.

What stocks does Andres Maldonado cover?

Andres Maldonado currently covers 4 stocks, including SRRK, ENGN, PVLA, CGON.

What is Andres Maldonado's latest price target?

Andres Maldonado's most recent price target was $58.00 on SRRK (Scholar Rock Holding Corporation), set on Jan 26, 2026.

What is Andres Maldonado's highest price target?

Andres Maldonado's highest issued price target is $75.00 on CGON, set on Sep 17, 2024.

Coverage based on publicly published price targets. Not investment advice.